Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer-Reference-Cited by-同舟云学术

Mapping of TMPRSS2–ERG fusions in the context of multi-focal prostate cancer

Published:2007-12-07 Issue:2 Volume:21 Page:67-75
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Furusato Bungo,Gao Chun-Ling,Ravindranath Lakshmi,Chen Yongmei,Cullen Jennifer,McLeod David G,Dobi Albert,Srivastava Shiv,Petrovics Gyorgy,Sesterhenn Isabell A

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800981.pdf

Reference45 articles.

1. Byar DP, Mostofi FK . Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 1972;30:5–13.

2. McNeal JE, Price HM, Redwine EA, et al. Stage A versus stage B adenocarcinoma of the prostate: morphological comparison and biological significance. J Urol 1988;139:61–65.

3. Villers A, McNeal JE, Freiha FS, et al. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 1992;70:2313–2318.

4. Stamey TA, McNeal JE, Yemoto CM, et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395–1400.

5. Griewe GL, Dean RC, Zhang W, et al. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein. Prostate Cancer Prostatic Dis 2003;6:281–285.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Pathology of Prostate Cancer;Clinics in Laboratory Medicine;2024-06

2. Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

3. Very large hidden genetic diversity in one single tumor: evidence for tumors-in-tumor;National Science Review;2022-11-11

4. Determination of ERG (+), EZH2 , NKX3.1 , and SPINK‐1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer;Cancer Reports;2022-10-05

5. The evolving landscape of prostate cancer somatic mutations;The Prostate;2022-06-03